Several U.S. government-funded HIV/AIDS clinical research sites in Africa will join other collaborators in an ongoing clinical trial testing an investigational tuberculosis (TB) vaccine in infants at risk for TB infection. “We are pleased to be able to tap into our existing HIV/AIDS clinical research infrastructure to help test promising investigational vaccines against TB,” said [...]
ALK today announced the initiation of its landmark GRAZAX® Asthma Prevention (GAP) trial.
GAP will be the largest ever trial to investigate the asthma preventive effect of specific immunotherapy in children (5–12 years old) with allergic grass pollen rhinoconjunctivitis, commonly known as ‘hay fever’. The European, multicentre, placebo-controlled, double-blind trial will follow approximately 600 children with a diagnosis of grass pollen allergic rhinoconjunctivitis over a period of 5 [...]
Sensium at the heart of digital healthcare
Cost and regulatory pressures on the hospital system are intense and set to increase for healthcare providers. Traditional care models in the hospital environment currently rely on manual techniques and “spot-check” observation of patients, which is not only expensive, but also inefficient and prone to error. In outpatient scenarios, the huge escalation in the incidence [...]
Malcolm Gladwell Health care innovations needs Cezanne-like innovators
Keynote speaker and social commentator Malcolm Gladwell (author of Outliers, Blink and The Tipping Point) whose gift for articulating fresh ideas has influenced a generation of business leaders, was present at iSOFT‘s Ideaworks for Healthcare 09. Mr Gladwell opened the discussion by addressing whether we are at healthcare’s ‘Tipping Point’ and how to accelerate a [...]
iSOFT Brings Together Leading Thinkers at ‘Ideaworks For Healthcare’
iSOFT Group Limited – one of the world’s biggest healthcare technology companies, brought together the world’s leading thinkers and creators of change to debate, challenge and discuss ideas on the future of healthcare innovation at its inaugural Ideaworks for Healthcare symposium in London this month. Ideaworks 09 (www.ideaworksforhealthcare.com) – which will be held at The [...]
Ticagrelor Achieves Greater Efficacy In Trial
AstraZeneca PLc (AZN) Tuesday announced results from the phase III head to head trial, PLATO – a study of platelet inhibition and patient outcomes – which demonstrate that ticagrelor (BrilintaTM) has achieved greater efficacy in the primary endpoint, reduction of cardiovascular events over clopidogrel (9.8% vs 11.7% at 12 months; 16% RRR; 95% CI, 0.77 [...]
Recent Comments